A Single Rising Dose Study of MK-8150 (MK-8150-001)

Clinical trial NCT01590810 · COMPLETED

Trial details

NCT number: NCT01590810
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension Isolated Systolic Hypertension (ISH)

Start date: 2012-05-07
Primary completion: 2013-01-24
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.